Related Experiment Video
Updated: Jun 6, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
ZNF331 Represses the Proliferation of Head and Neck Squamous Cell Carcinoma via Co-Repressor TRIM28
Ju Li1,2, Hao Cheng3, Yong Zhao3
1Department of Stomatology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Objective:
This study aims to explore the regulatory effect of Zinc Finger Protein 331 (ZNF331), a KRAB domain-containing transcriptional repressor, in Head and Neck Squamous Cell Carcinoma (HNSCC).
Materials And Methods:
Data from The Cancer Genome Atlas (TCGA)-HNSC were analyzed. The roles of ZNF331 in HNSCC cell proliferation, cell cycle progression, and its interacting proteins were explored through in vitro manipulation of ZNF331 expression and in vivo xenograft experiments. The epigenetic mechanisms underlying ZNF331 dysregulation were investigated by assessing its promoter methylation and the effects of DNA methyltransferase (DNMT) knockdown.
Results:
Patients with higher ZNF331 expression had a significantly improved progression-free interval (PFI). ZNF331 overexpression inhibits HNSCC cell proliferation and induces G2/M arrest, while its knockdown enhances oncogenic features. ZNF331 can downregulate the expression of oncogenes such as DDX5, EIF5A, and SET. ZNF331's tumor-suppressive activity requires TRIM28, a universal co-repressor of KRAB-ZNF proteins. ZNF331 expression is suppressed by DNMT3B-mediated promoter hypermethylation. Selective knockdown of DNMT3B, but not DNMT3A, restored ZNF331 expression.
Conclusions:
ZNF331 acts as a potential tumor suppressor in HNSCC, whose inactivation through DNMT3B-mediated hypermethylation may contribute to HNSCC tumorigenesis. Restoring ZNF331 expression through targeted epigenetic therapies may offer a novel strategy for the treatment of HNSCC.
Insights
Zinc Finger Protein 331 (ZNF331) suppresses Head and Neck Squamous Cell Carcinoma (HNSCC) growth. Its inactivation via DNA methylation contributes to HNSCC, suggesting ZNF331 restoration as a potential therapy.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Head and Neck Squamous Cell Carcinoma (HNSCC) is a complex malignancy.
- The role of Zinc Finger Protein 331 (ZNF331), a transcriptional repressor, in HNSCC remains largely unexplored.
Purpose of the Study:
- To investigate the regulatory role of ZNF331 in HNSCC.
- To elucidate the mechanisms underlying ZNF331 dysregulation and its impact on tumor progression.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA)-HNSC data.
- In vitro and in vivo experiments assessing ZNF331's effects on cell proliferation, cell cycle, and oncogene expression.
- Investigation of epigenetic modifications, including promoter methylation and DNA methyltransferase (DNMT) activity.
Main Results:
- Higher ZNF331 expression correlates with improved progression-free survival in HNSCC patients.
- ZNF331 overexpression inhibits HNSCC proliferation and induces G2/M arrest, while knockdown promotes oncogenesis.
- ZNF331 downregulates oncogenes (DDX5, EIF5A, SET) and requires TRIM28 for its tumor-suppressive function.
- DNMT3B-mediated promoter hypermethylation suppresses ZNF331 expression; DNMT3B knockdown restores it.
Conclusions:
- ZNF331 functions as a tumor suppressor in HNSCC.
- DNMT3B-mediated hypermethylation inactivates ZNF331, contributing to HNSCC development.
- Restoring ZNF331 expression via epigenetic therapy presents a potential treatment strategy for HNSCC.
Related Concept Videos
Co-activators and Co-repressors
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

